Pleiotrophin inhibits transforming growth factor β1-induced apoptosis in hepatoma cell lines

Molecular Carcinogenesis

Volumn 47, Issue 10, 2008, Pages 784-796

  Tae, Jun Park ^a   Bo, Ra Jeong ^a   Tateno, Chise ^b,e   Hong, Seok Kim ^a   Ogawa, Tomohiro ^c,d   In, Kyoung Lim ^a   Yoshizato, Katsutoshi ^b,c,d,e  

^a Ajou University School of Medicine   (South Korea)

^b Hiroshima Prefectural Institute of Industrial Science and Technology   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

^e PhoenixBio USA Corporation   (Japan)

Author keywords

Caspase 3; Hepatic stellate cells; Hepatocarcinogenesis; Liver fibrosis; Pleiotrophin; TGF 1

Indexed keywords

ADENOVIRUS VECTOR; CARBON TETRACHLORIDE; CASPASE 3; CYTOKINE; MESSENGER RNA; MITOMYCIN C; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLEIOTROPHIN; PROCASPASE 3; PROCASPASE 8; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; CARRIER PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; GENE EXPRESSION; GENETIC TRANSFECTION; HEPATOMA CELL; HUMAN; HUMAN CELL; KUPFFER CELL; LIVER CARCINOGENESIS; LIVER CELL; LIVER FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; STELLATE CELL; ANIMAL; FISCHER 344 RAT; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER TUMOR; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

RATTUS;

ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL LINE, TUMOR; CYTOKINES; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 52649174410     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20438     Document Type: Article

References (36)

1. Deuel TF, Zhang N, Yeh HJ, Silos-Santiago I, Wang ZY. Pleiotrophin: A cytokine with diverse functions and a novel signaling pathway. Arch Biochem Biophys 2002;397:162-171.
2. Milner PG, Li YS, Hoffman RM, Kodner CM, Siegel NR, Deuel TF. A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: Purification and N-terminal amino acid sequence. Biochem Biophys Res Commun 1989;165:1096-1103.
3. Li YS, Milner PG, Chauhan AK, et al. Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 1990;250:1690-1694.
4. Kadomatsu K, Tomomura M, Muramatsu T. cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun 1988;151:1312-1318.
5. Laaroubi K, Delbe J, Vacherot F, et al., Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide. Growth Factors 1994;10:89-98.
6. Asahina K, Sato H, Yamasaki C, et al. Pleiotrophin/heparin-binding growth-associated molecule as a mitogen of rat hepatocytes and its role in regeneration and development of liver. Am J Pathol 2002;160:2191-2205.
7. Chauhan AK, Li YS, Deuel TF. Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice. Proc Natl Acad Sci USA 1993;90:679-682.
8. Chen H, Gordon MS, Campbell RA, et al. Pleiotrophin is highly expressed by myeloma cells and promotes myeloma tumor growth. Blood 2007;110:287-295.
9. Sato H, Funahashi M, Kristensen DB, Tateno C, Yoshizato K. Pleiotrophin as a Swiss 3T3 cell-derived potent mitogen for adult rat hepatocytes. Exp Cell Res 1999;246:152-164.
10. Kohashi T, Tateaki Y, Tateno C, Asahara T, Obara M, Yoshizato K. Expression of pleiotrophin in hepatic non-parenchymal cells and preneoplastic nodules in carbon tetrachloride-induced fibrotic rat liver. Growth Factors 2002;20:53-60.
11. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991;350:427-428.
12. Moriya K, Fujie H, Shintani Y, et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998;4:1065-1067.
13. Thorgeirsson SS, Teramoto T, Factor VM. Dysregulation of apoptosis in hepatocellular carcinoma. Semin Liver Dis 1998;18:115-122.
14. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-218.
15. Miwa Y, Harrison PM, Farzaneh F, Langley PG, Williams R, Hughes RD. Plasma levels and hepatic mRNA expression of transforming growth factor-beta 1 in patients with fulminant hepatic failure. J Hepatol 1997;27:780-788.
16. Carr BI, Hayashi I, Branum EL, Moses HL. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor. Cancer Res 1986;46:2330-2334.
17. Strain AJ, Frazer A, Hill DJ, Milner RD. Transforming growth factor beta inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver. Biochem Biophys Res Commun 1987;145:436-442.
18. Caja L, Ortiz C, Bertran E, et al. Differential intracellular signaling induced by TGF-beta in rat adult hepatocytes and hepatoma cells: Implications in liver carcinogenesis. Cell Signal 2007;19:683-694.
19. Nakamura T, Sakata R, Ueno T, Sata M, Ueno H. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology 2000;32:247-255.
20. Park YN, Chae KJ, Kim YB, Park C, Theise N. Apoptosis and proliferation in hepatocarcinogenesis related to cirrhosis. Cancer 2001;92:2733-2738.
21. Lim IK, Park SC, Song KY, et al. Regulation of selection of liver nodules initiated with N-nitrosodiethylamine and promoted with nodularin injections in fischer 344 male rats by reciprocal expression of transforming growth factor-beta1 and its receptors. Mol Carcinog 1999;26:83-92.
22. Fan G, Ma X, Kren BT, Steer CJ. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Oncogene 1996;12:1909-1919.
23. Black D, Lyman S, Qian T, et al. Transforming growth factor beta mediates hepatocyte apoptosis through Smad3 generation of reactive oxygen species. Biochimie 2007;89:1464-1473.
24. Shima Y, Nakao K, Nakashima T, et al. Activation of caspase-8 in transforming growth factor-beta-induced apoptosis of human hepatoma cells. Hepatology 1999;30:1215-1222.
25. Tateno C, Takai-Kajihara K, Yamasaki C, Sato H, Yoshizato K. Heterogeneity of growth potential of adult rat hepatocytes in vitro. Hepatology 2000;31:65-74.
26. Kristensen DB, Kawada N, Imamura K, et al. Proteome analysis of rat hepatic stellate cells. Hepatology 2000; 32:268-277.
27. Tewari M, Quan LT, O'Rourke K, et al. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995;81:801-809,
28. Czaja MJ, Weiner FR, Flanders KC, et al. In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis. J Cell Biol 1989;108:2477-2482.
29. Armendariz-Borunda J, Seyer JM, Kang AH, Raghow R. Regulation of TGF beta gene expression in rat liver intoxicated with carbon tetrachloride. FASEB J 1990;4:215-221.
30. Lim IK, Joo HJ, Choi KS, et al. Protection of 5alpha-dihydrotestosterone against TGF-beta-induced apoptosis in FaO cells and induction of mitosis in HepG2 cells. Int J Cancer 1997;72:351-355.
31. Gressner AM, Lahme B, Brenzel A. Molecular dissection of the mitogenic effect of hepatocytes on cultured hepatic stellate cells. Hepatology 1995;22:1507-1518.
32. Lissoos TW, Davis BH. Pathogenesis of hepatic fibrosis and the role of cytokines. J Clin Gastroenterol 1992;15:63-67.
33. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376:37-43.
34. Schulte-Hermann R, Bursch W, Kraupp-Grasl B, Oberhammer F, Wagner A. Programmed cell death and its protective role with particular reference to apoptosis. Toxicol Lett 1992;64-65:569-574.
35. Oberhammer F, Bursch W, Tiefenbacher R, et al. Apoptosis is induced by transforming growth factor-beta 1 within 5 hours in regressing liver without significant fragmentation of the DNA. Hepatology 1993;8:1238-1246.
36. George J, Roulot D, Koteliansky VE, Bissell DM. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: A potential new therapy for hepatic fibrosis. Proc Natl Acad Sci USA 1999;96:12719-12724.